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Abstract Metabolic imaging has a potential for better under-
standing of pathophysiology of heart failure. C-11 acetate is
taken up by the heart, rapidly converted to acetylCoA and
readily metabolized to C-11 CO2 through TCA cycle with
oxidative phosphorylation. Thus, the myocardial turnover rate
of this tracer is tightly correlated with its clearance of C-11
CO2, reflecting overall oxidative metabolism. The heart relies
on aerobic oxidative substrate for the generation of ATP, which
is required to maintain its contractile function. The progression
to heart failure is associated with a gradual decline in the
activity of mitochondrial respiratory pathways, leading to di-
minished capacity for ATP production. The work metabolic
index can also be estimated by the combination of C-11 acetate
PET and hemodynamics by echocardiography, the metabolic
index is a significant marker to understand the pathophysiology
of heart failure as well as myocardial oxidative metabolism.
Keywords Oxidativemetabolism . Heart failure . C-11
acetate . Positron emission tomography .Metabolic work index
Introduction
Metabolic imaging has a potential for better understanding of
pathophysiology of heart failure. The advantage of tracer
techniques is to use a radiolabeled compound for in vivo
quantification of specific biological processes. With introduc-
tion of positron emission tomography (PET), the spectrum of
in vivo tissue characterization has been widened with use of
physiological tracers labeled with C-11, N-13, O-15, and F-18
which allow the synthesis of naturally occurring and biolog-
ically active compounds. The importance of energy metabo-
lism in maintaining the integrity of cardiac performance has
been increasingly recognized with PET.
C-11 palmitate and F-18 fluorodeoxyglucose (FDG) are
used to estimate myocardial metabolism with myocardial
energy substrate such as fatty acid and glucose utilizations,
respectively by PET. On the other hand, a direct estimate of
tricarboxylic acid (TCA) cycle is an alternative approach for
assessing myocardial metabolism. C-11 acetate has been pro-
posed as a PET tracer to probe myocardial oxidative metabo-
lism with PET. This tracer, a simple two-carbon carboxylic
acid, can be rapidly prepared in high yields by the simple one
step C-11 carboxylation of the appropriate Grinard reagent,
methylmagnesium bromide [1].
C-11 acetate is taken up by the heart, rapidly converted to
acetylCoA and readily metabolized to CO2 through TCA
cycle with oxidative phosphorylation. Thus, the myocardial
turnover rate of this tracer is tightly correlated with its clear-
ance of C-11 CO2, reflecting overall oxidative metabolism.
The myocardial clearance rate following intravenous admin-
istration of C-11 acetate correlates closely with myocardial
oxygen consumption measured by arterial-venous difference
of oxygen in isolated heart preparation during ischemia and
reperfusion [2, 3]. While metabolic studies with C-11 palmi-
tate or FDG studies are quite dependent on plasma substrate
levels, C-11 acetate metabolism is independent of concentra-
tion of energy substrates for the myocardium [4, 5].
How to Analyze Oxidative Metabolism
Following administration of 10–20mCi (370-740MBq) of C-
11 acetate, dynamic PET acquisition is performed over 20–
30 minutes. A rapid clearance of blood pool activity and high
myocardial uptake create high quality myocardial images with
high target-to-background ratio a few minutes after tracer
administration. A uniform washout from the left ventricular
myocardium is obtained in the normal subjects, indicating a
homogeneous oxidative metabolism. A mono-exponential or
bi-exponential least square fitting can be applied to the
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regional myocardial time activity curves. The Kmono or K1
values are used as indices of regional myocardial oxidative
metabolism. This is a simple method for the quantitative
analysis of washout kinetics of this tracer (Fig. 1) [5–7].
In vivo canine studies with C-11 acetate and PET delineated
the chronology of restoration of oxidative metabolism with
respect to recovery of systolic function and changes in substrate
utilization after reperfusion [7–9]. Following a short period of
ischemia, both oxidative metabolism and systolic function were
reduced but both parameters increased in response to inotropic
stimulation by pacing, indicating stunnedmyocardium showing
both oxidative and functional reserve [10]. Following longer
periods (1–3 hrs) of ischemia, oxidative metabolism did not
return to baseline levels until at least 2–6 weeks which is
paralleled with the results of recovery of systolic function
[11]. These experimental results indicate the importance of
the recovery of oxidative metabolism in predicting the recov-
ery of systolic function following myocardial ischemia.
The human experiments also showed the close estimates of
myocardial oxygen consumption by the C-11 acetate kinetic
study [9]. One of the major importances of this analysis is that
the relationship of the turnover rate of this tracer is relatively
insensitive to changes in the substrate environment.
When the estimate of myocardial oxygen consumption by
C-11 acetate PET is compared with measurement of left ven-
tricular external work, work metabolic index can be calculated
[11–13]. Mechanical efficiency is the external work corrected
for total myocardial oxygen consumption. Noninvasively, effi-
ciency can be estimated by combining echocardiographic
stroke work, mean blood pressure, and oxygen consumption
estimated by C-11 acetate PET [11–13]. This approach indi-
cates a significant promise as a means to delineate mechanics
Fig. 1 Monoexponential
clearance rate of C-11 acetate for
the myocardium (Kmono) (a).
Polar map in patients with dilated
cardiomyopathy. Kmono before
and after surgery (b) and C-11
acetate imaging (early phase) of
short-axis view in the midlevel
before and after surgery (c).
Kmono value did not change,
whereas left ventricular size
decreased after surgery [43••]
9244, Page 2 of 7 Curr Cardiovasc Imaging Rep (2014) 7:9244
responsible for cardiac function and treatment effect in patients
with poor ventricular dysfunction.
Clinical Applications for Ischemic Heart Disease
C-11 acetate PET permits observation of the effects of acute
ischemia on oxidative metabolism in a clinical setting in
patients with acute myocardial infarction similar to the exper-
imental model [14]. In addition, the time course of restoration
of metabolism can be analyzed in relation to recovery of
myocardial perfusion and function after thrombolysis. Henes
et al. [15] indicated markedly reduced metabolism in the
central zone of infarction with no change over time in patients
with conservative treatment. In contrast, in patients with acute
myocardial infarction with successful thrombolysis, perfusion
was normalized within 24 hours, whereas oxidative metabo-
lism was impaired initially and increased slowly over time. In
addition, the improvement in regional systolic function was
only seen in those with normal perfusion and improvement in
metabolism. Kalff et al. [16] indicated the reduction of oxida-
tive metabolism in normal myocardium by beta-blockade,
indicating myocardial protection. Czernin et al. [17] demon-
strated the preserved oxidative metabolism in the areas with
flow and glucose metabolismmismatch in patients with recent
myocardial infarction, suggesting regional increase in oxygen
extraction in combination of enhanced glucose metabolism.
These data indicate frequent dissociation of regional perfusion
and oxidative metabolism after myocardial infarction, and
potential value for assessing oxidative metabolism in compar-
ison with perfusion for precise assessment of tissue function in
infarcted and peri-infarcted areas. Vanoverschelde et al. [18]
showed that regional flow and oxidative metabolism were
well preserved in the chronically dysfunctional areas without
prior myocardial infarction. They proposed that such areas
result from repeated episodes of ischemia.
Assessment of myocardial viability has been focused in the
clinical studies using PET. Because of the importance of
preservation of oxidative metabolism for the recovery of
ventricular dysfunction after ischemia, C-11 acetate PET has
been applied for tissue viability analysis. Gropler et al. first
reported value of oxidative metabolism assessed by dynamic
PET with C-11 acetate for differentiation of viable from non-
viable myocardium [19]. The preservation of oxidative me-
tabolism may be required for recovery of function after coro-
nary revascularization in patients with chronic coronary artery
disease [20, 21]. This concept has been extended to patients
after acute myocardial infarction. Hicks et al. [22] explored
the value of C-11 acetate for predicting long-term outcome in
regional contractile function in infarct territories. This study
employs the initial uptake of this tracer as ameasure of relative
regional blood flow [23, 24] to compare relative acetate clear-
ance. Concordant reduction of blood flow and oxidative
metabolism may indicate nonviable myocardium, and thus,
lack of long-term improvement in contractile function. On the
contrary, those with greater reduction of oxidative metabolism
than blood flow appeared to predict future improvement in
contractile function. Wolpers et al. [25] indicated a certain
threshold of regional perfusion and oxidative metabolism for
recovery of regional dysfunction. The areas beyond the
threshold may be irreversibly injured myocardium. Hicks
et al. [22], on the other hand, showed significant overlap of
absolute values of oxidative metabolism between reversible
and nonreversible segments after acute myocardial infarction.
Comparison of regional perfusion and oxidative metabolism
was more predictive of recovery in contractive function.
In patients with left ventricular dysfunction in patients with
coronary artery disease, assessment of oxidative metabolism
provided an incremental increase in accuracy compared with
glucose metabolic study [26, 27]. This superiority of oxidative
metabolism over glucose metabolismmay be derived from the
inability of FDG kinetics to separate the oxidative from
nonoxidative component of glucose metabolism. In addition,
assessment of oxidative metabolism requires no standardiza-
tion of energy substrates. On the other hand, Vanoverschelde
et al. [28] in the study of patients with reperfused myocardial
infarction showed the reduction of oxidative metabolism in
proportion of residual myocardial blood flow and no differ-
ence in the metabolic value with and without flow-FDG
mismatch. According to their findings, oxidative metabolism
may not provide additional independent information regard-
ing myocardial viability over the combined evaluation of
residual flow and glucose metabolism. However, many more
case studies are required to confirm these findings.
PET study with C-11 acetate at rest and dobutamine infu-
sion provides promising approach for assessment of oxidative
metabolic reserve [5, 29]. Hata et al. [30] reported that oxida-
tive metabolic reserve after low-dose dobutamine infusion was
the better marker of recovery of regional function than the
resting oxidative metabolism. On the other hand, Yoshinaga
et al. [31] demonstrated reduced oxidative metabolic reserve
despite preserved glucose utilization in severely dysfunctional
myocardium. Such decrease in oxidative metabolic reserve
may come from impaired mitochondrial response to inotropic
stimulation. Further analysis is warranted to investigate mito-
chondrial function in relation to inotropic reserve as well as
functional analysis before and after intervention may play an
important role for assessing tissue viability.
Clinical Applications for Heart Failure
The heart failure has a significant impact on quality of life and
prognosis. The heart relies almost exclusively on aerobic
oxidative substrate for the generation of ATP, which is re-
quired to maintain its contractile function. The progression to
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heart failure is associated with a gradual decline in the activity
of mitochondrial respiratory pathways, leading to diminished
capacity for ATP production [32]. For the better understanding
of the pathophysiology, it is important to assess myocardial
oxidative metabolism.
Abnormal oxidative metabolism is often observed in pa-
tients with cardiomyopathy. Tadamura et al. [33] showed
decreased Kmono values both in the hypertrophic and non-
hypertrophic myocardium, indicating regional decrease in
oxidative metabolism in patients with hypertrophic cardiomy-
opathy. Some of these areas were associated with enhanced
FDG uptake, whereas others showed concordant decrease in
FDG uptake. These findings were not related with cardiac
symptoms or familial history of cardiomyopathy. In the study
of patients with dilated cardiomyopathy, Bach et al. [34]
indicated heterogeneity of regional oxidative metabolism in
proportion to heterogeneous ventricular dysfunction on echo-
cardiography. Heterogeneous reduction of oxidative metabo-
lism was also noted not only in ischemic cardiomyopathy but
also in dilated cardiomyopathy [35]. If particular, severe re-
duction of oxidative metabolism was noted in septal regions
as compared to other regions in patients with left bundle
branch block [35].
Aortic Stenosis
Myocardial oxidative metabolism measured 11C-acetate PET
is significantly increased by about 40 % in patients with
moderate to severe aortic stenosis and preserved systolic
volume index compared with healthy controls [36, 37••].
Estimated systolic left ventricular pressure measured by echo-
cardiography was independently associated with the increased
myocardial oxidative metabolism (Fig. 2). Importantly, aortic
valve replacement ameliorates left ventricular hypertrophy as
well as increased oxidative metabolism in patients with aortic
stenosis (Fig. 3), indicating that Kmono may be interpreted as
a new indicator of myocardial wall stress. Selection of aortic
stenosis patients for surgery is generally determined by their
symptoms. However, there are many clinical settings such as
age and physical disability in which the optimal timing of
surgery can be hardly determined. Thus, Kmono estimation
may help clinicians to determine the optimal timing for aortic
valve replacement for these patients, which, however, needs to
be assessed by a well-designed clinical study in the future.
Effects of Medical Therapy on Work Metabolic Index in Left
Ventricular Dysfunction
The concept of work metabolic index estimated by the com-
bination of 11C-acetate PET and hemodynamics has been
raised by Beanlands et al. [11]. The work metabolic index
was determined as follow: Work metabolic index=(systolic
volume index * systolic blood pressure *heart rate)/ kmono.
This equation is a modification of the equation for left ven-
tricular mechanical efficiency described by Bing et al. [38]
and well validated with coronary sinus flow and oxygen
consumption measurements by using pulmonary artery and
coronary sinus catheter.
In patients with systolic dysfunction, there is a modest
inverse relationship between Kmono and LVEF (Fig. 4). Es-
pecially, severe systolic dysfunction is related to low work
metabolic index. This work metabolic index seems to be
expected to closely relate with the progression of LV remod-
eling leading to cardiac death. Beanlands et al. demonstrated
the excellent study looking at the effects of beta-blockade on
the work metabolic index in a double control study. Three
months after therapy, Kmono is significantly decreased by
24 % in metoprolol group compared to placebo group (5 %
reduction) without change in blood pressure and systolic
volume index, results in significant increase in work metabol-
ic index (39 % increase) by metoprolol. Similarly, exercise
training improves work metabolic index in patients with di-
lated cardiomyopathy [39]. They found that exercise training
Fig. 2 Relationship between Kmono and systolic LV pressure estimated
by echocardiography and systolic blood pressure in healthy controls (n=
7) and patients with AS (n=16) [37••]
Fig. 3 Changes in Kmono before and 1 month after aortic valve replace-
ment in patients with aortic stenosis (n=5) [37••]
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prescribed as 70 % of peak VO2 for 45 mins twice a weak
significantly increases work metabolic index by 24.3 %,
which is significantly higher than that of control group
(4.3 %). In patients who have severe systolic and wide QRS
complex, cardiac resynchronized therapy is effective treat-
ment to increase work metabolic index [40, 41], which is
caused by homogeneity of metabolism in left ventricle by
cardiac resynchronized therapy. These results suggest that
intensive medical therapy for treatment of heart failure im-
proves cardiac function in part via improvement of work
metabolic index. In patients with refractory heart failure under
the optical medical therapy, surgical ventricular reconstruction
and mitral complex reconstruction is another therapy [42]
although the surgery is not proven to improve outcome. In a
pilot study demonstrated by Sugiki et al., the surgery improves
the work metabolic index in all six patients with non-ischemic
dilated cardiomyopathy and five of six patients with ischemic
cardiomyopathy, indicating that the new integrated procedure
can be applied for dilated cardiomyopathy [43••] (Fig. 5).
However, the optimal timing for our procedure and responders
warranted to be investigated in a larger population.
Mitral Regurgitation
Chow et al. demonstrates the effects of mitral valve surgery on
“forward work metabolic index in patients with severe mitral
regurgitation [44]. The authors calculate a regurgitation work
index (regurgitation volume * peak left atrial pressure / body
surface area). In patients with significant mitral regurgitation
(regurgitation volume=34 +/− 19 mL), the index is 0.705 +/−
0.176*106. This is 12 % of total work metabolic index (for-
ward plus regurgitation). After mitral valve surgery, this
regurgitation work index becomes almost zero as expect.
Accordingly, forward work metabolic index significantly in-
creases from 4.99 +/− 1.32 *106 to 6.59 +/− 2.45 * 106. This
study clarifies the effects of volume overload of the left
ventricle on cardiac metabolism and efficiency.
Oxidative Metabolism in Right Ventricle
C-11 acetate PET is useful to estimate right ventricular oxida-
tive metabolism although catheter is limited to estimate the
metabolism due to the complex morphology of right ventricle
[45]. In this study, C-11 clearance of right ventricular free wall
rate is correlated with the product of systolic pulmonary artery
pressure and heart rate for all patients (r=0.65, p=0.002), but
the relation was stronger if two patients with overt RV dys-
function were excluded (r=0.83, p=0.001), suggesting that C-
11 acetate PET may allow the assessment of RV metabolism
in patients with right ventricular dysfunction. This could be
applied in adult congenital heart diseases and severe heart
failure under left ventricular-assist device, and the effects of
therapeutic interventions on right ventricular dysfunction. The
assessment of right ventricular oxidative metabolism is also
variable to understand the wall stress of right ventricular wall
in patients with idiopathic pulmonary arterial hypertension.
Wong et al. reported about a series of 26 patients, who
underwent C-11 acetate and PET [46•]. They observed a
positive relationship between right ventricular Kmono and
rate-pressure product of pulmonary artery in patients with
idiopathic pulmonary arterial hypertension. This finding is
important to understand the effects of pressure overload on
metabolism in right ventricle.
Conclusions
C-11 labeled compounds have unique character to radiolabeled
natural compound, physiological and biochemical processes
can be assessed in vivo. If particular, C-11 acetate are both
Fig. 5 Work metabolic index in patients with dilated cardiomyopathy
(DCM) and ICM before and after surgery. The work metabolic index
increased in all patients with DCM and in 5 of 6 patients with ICM [43••]
Fig. 4 Correlation between left ventricular ejection fraction and global
myocardial oxidative metabolism in patients with left ventricular dys-
function [35]
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rapidly taken up in the myocardium and incorporated in the
metabolic process to excrete from the myocardium as C-11
carbon dioxide. Therefore, the turnover rate of these tracers can
reflect oxidative metabolism. This technique provides precise
insights into pathophysiology in various conditions of myocar-
dial ischemia and heart failure. Oxidative metabolism is a
fundamental major energy source in the myocardium. Thus,
oxidative metabolic analysis should play an important role for
assessing myocardial viability and treatment effects in the
patients with coronary artery disease. Furthermore, C-11 ace-
tate PET has recently been used for metabolic efficiency in
heart failure. Clinical impacts of such studies are warranted in
the future.
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